These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11253158)

  • 1. Functional status and health-related quality of life of elderly osteoarthritic patients treated with celecoxib.
    Lisse J; Espinoza L; Zhao SZ; Dedhiya SD; Osterhaus JT
    J Gerontol A Biol Sci Med Sci; 2001 Mar; 56(3):M167-75. PubMed ID: 11253158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib.
    Zhao SZ; Fiechtner JI; Tindall EA; Dedhiya SD; Zhao WW; Osterhaus JT; Yu SS
    Arthritis Care Res; 2000 Apr; 13(2):112-21. PubMed ID: 14635284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxib.
    Zhao SZ; McMillen JI; Markenson JA; Dedhiya SD; Zhao WW; Osterhaus JT; Yu SS
    Pharmacotherapy; 1999 Nov; 19(11):1269-78. PubMed ID: 10555933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
    Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS
    Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS
    J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American pain society pain questionnaire and other pain measures in the assessment of osteoarthritis pain: a pooled analysis of three celecoxib pivotal studies.
    Moskowitz RW; Sunshine A; Brugger A; Lefkowith JB; Zhao WW; Geis GS
    Am J Ther; 2003; 10(1):12-20. PubMed ID: 12522515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
    Bensen WG; Fiechtner JJ; McMillen JI; Zhao WW; Yu SS; Woods EM; Hubbard RC; Isakson PC; Verburg KM; Geis GS
    Mayo Clin Proc; 1999 Nov; 74(11):1095-105. PubMed ID: 10560596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip.
    Kivitz AJ; Moskowitz RW; Woods E; Hubbard RC; Verburg KM; Lefkowith JB; Geis GS
    J Int Med Res; 2001; 29(6):467-79. PubMed ID: 11803730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo.
    Bingham CO; Smugar SS; Wang H; Peloso PM; Gammaitoni A
    Pain Med; 2011 Mar; 12(3):352-61. PubMed ID: 21332932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.
    Fleischmann R; Sheldon E; Maldonado-Cocco J; Dutta D; Yu S; Sloan VS
    Clin Rheumatol; 2006 Feb; 25(1):42-53. PubMed ID: 16132165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of celecoxib versus naproxen in patients with osteoarthritis of the knee: a randomized, double-blind, double-dummy trial.
    Essex MN; Bhadra P; Sands GH
    J Int Med Res; 2012; 40(4):1357-70. PubMed ID: 22971487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of nonsteroidal anti-inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo-controlled study.
    Essex MN; O'Connell MA; Behar R; Bao W
    Int J Rheum Dis; 2016 Mar; 19(3):262-70. PubMed ID: 25990559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain.
    Clemett D; Goa KL
    Drugs; 2000 Apr; 59(4):957-80. PubMed ID: 10804043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Cryer BL; Sostek MB; Fort JG; Svensson O; Hwang C; Hochberg MC
    Ann Med; 2011 Dec; 43(8):594-605. PubMed ID: 22017620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial.
    Gibofsky A; Williams GW; McKenna F; Fort JG
    Arthritis Rheum; 2003 Nov; 48(11):3102-11. PubMed ID: 14613272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen.
    Makarowski W; Zhao WW; Bevirt T; Recker DP
    Osteoarthritis Cartilage; 2002 Apr; 10(4):290-6. PubMed ID: 11950252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
    Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U
    Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials.
    Hochberg MC; Fort JG; Svensson O; Hwang C; Sostek M
    Curr Med Res Opin; 2011 Jun; 27(6):1243-53. PubMed ID: 21524238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.